文献速递胃肠外科围术期管理与 ERAS

机器人食管裂孔疝修补术后5年翻修预测因素的系统综述

Adults undergoing robotic hiatal hernia repair: do surgical and patient factors predict 5-year revision? A systematic review.
PubMed 文献 · Surg Endosc · 2026-07-16

该系统综述纳入15项研究(14个独立队列),评估成人机器人食管裂孔疝修补术后5年内翻修或复发的预测因素。结果显示疝大小是最强预测因子,5年加权平均翻修率约3.2%,大疝或巨大疝翻修率显著升高,部分系列达30%。补片加固与较低翻修率相关但证据受限。

要点

  • 疝大小是机器人食管裂孔疝修补术后翻修的最强预测因素。
  • 5年加权平均翻修率约3.2%,各研究报告范围0–5.7%。
  • 补片加固修复翻修率2–4%,非补片修复为6–8%,但证据受限。

核心结论

  • 疝大小一致地成为机器人食管裂孔疝修补术后翻修的主要决定因素,无论手术方式如何,较大疝的翻修率显著更高。
  • 基于现有数据,机器人食管裂孔疝修补术的5年翻修率为0–5.7%,估计加权平均值约3.2%。
  • 补片加固和重建方法等技术因素因研究报告差异大而尚未完全明确。
  • 患者特异性因素需通过足够把握度的前瞻性研究进一步探究。

研究设计与样本

  • 系统综述,遵循PRISMA 2020指南,检索PubMed/MEDLINE、Embase、Cochrane Library和Web of Science自建库至2025年7月。
  • 纳入标准为成人初次机器人食管裂孔疝修补术(≥10例患者)且报告翻修或复发并随访至少12个月的研究。
  • 共纳入15项研究,包含14个独立患者队列;其中参考文献6和7报告同一1834例患者系列,其中486例为机器人手术。
  • 因临床和方法学异质性大,未进行正式定量荟萃分析,而是采用结构化描述性综合并在数据允许时进行样本量加权合并估计。
  • 方法学质量使用Newcastle-Ottawa量表评估,两名评价者独立筛选和提取数据,分歧由第三名评价者解决。

主要发现

  • 总体复发率范围为5%至15%,大多数复发发生在术后前2年内。
  • 各研究报告的翻修率范围为0至5.7%,5年随访时加权平均翻修率约3.2%。
  • 大疝或巨大疝(≥5 cm或>50%胃 intrathoracic 迁移)翻修率显著升高,某些系列达30%。
  • 小到中等疝(<5 cm)翻修率为0–2%,大疝(5–10 cm)为5–12%,巨大疝(>10 cm)为15–30%。
  • 约60%的研究记录了补片使用;在明确补片使用的研究中,补片加固修复翻修率为2–4%,非补片修复为6–8%。

关键数值与推荐

  • 疝大小分层:小到中等疝(<5 cm)翻修率0–2%,大疝(5–10 cm)5–12%,巨大疝(>10 cm)15–30%。
  • 5年加权平均翻修率约3.2%,范围0–5.7%。
  • 补片加固修复翻修率2–4%,非补片修复6–8%(异质性妨碍确定性统计分析)。
  • 患者因素包括BMI>35 kg/m2、年龄>70岁和合并症(糖尿病、慢性类固醇使用)与翻修风险的关联不一致,仅6/14个队列进行了多变量分析控制混杂因素。

临床怎么用

  • 临床应重视疝大小对翻修风险的预测价值,对Large或巨大疝患者加强术后随访和患者咨询。
  • 补片加固可能降低翻修风险,但需考虑研究间报告异质性,决策应个体化。
  • 患者因素如BMI、年龄和合并症与翻修风险的关联尚不明确,需结合个体情况评估。

局限性

  • 因临床和方法学异质性大(疝大小标准、胃底折叠和脚关闭技术、结局定义和随访时长不一),未进行正式定量荟萃分析。
  • 补片使用报告不一致,仅约60%研究记录补片使用,妨碍确定性统计分析。
  • 技术变异(脚关闭技术和胃底折叠类型)在研究间未充分标准化。
  • 仅6/14个队列进行多变量分析控制混杂因素,患者因素关联不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic hiatal hernia repair (RHHR) has emerged as an innovative alternative to conventional laparoscopic techniques, offering potential advantages in visualization, dexterity, and ergonomics. However, predictors of revision surgery following RHHR remain incompletely understood. This systematic review investigates key surgical and patient factors associated with revision within 5 years following RHHR. METHODS: We systematically searched PubMed/MEDLINE, Embase, the Cochrane Library, and Web of Science from inception through July 2025 for studies reporting revision or recurrence after RHHR, following PRISMA 2020 guidance. Eligible studies enrolled adults undergoing primary RHHR (≥ 10 patients) and reported revision or recurrence with at least 12 months of follow-up. Two reviewers independently screened records and extracted data, with disagreements resolved by a third reviewer; methodological quality was appraised using the Newcastle-Ottawa Scale. Because of substantial clinical and methodological heterogeneity (variable hernia size criteria, fundoplication and crural closure techniques, outcome definitions, and follow-up duration), a formal quantitative meta-analysis was judged inappropriate; we therefore performed a structured descriptive synthesis with sample size-weighted pooled estimates where data permitted. RESULTS: Our analysis included 15 studies comprising 14 independent patient cohorts (references 6 and 7 report the same 1834-patient series, of which 486 were robotic) (Table 1). Overall recurrence rates ranged from 5 to 15%, with the majority of recurrences occurring within the first 2 postoperative years. Revision rates specifically ranged from 0 to 5.7% across studies, with a weighted average revision rate of approximately 3.2% at 5-year follow-up. Hernia size emerged as the strongest predictor of recurrence and revision-large or giant hernias (≥ 5 cm or > 50% intrathoracic stomach migration) demonstrated markedly elevated revision rates reaching 30% in certain series (Table 2; Fig. 2). Studies comparing hernia sizes showed that small to medium hernias (< 5 cm) had revision rates of 0-2%, while large hernias (5-10 cm) had rates of 5-12%, and giant hernias (> 10 cm) showed rates of 15-30%. Mesh reinforcement was inconsistently reported across studies, with approximately 60% of studies documenting mesh usage. Among studies that specified mesh utilization, mesh-reinforced repairs showed revision rates of 2-4% compared to 6-8% in non-mesh repairs (Table 3; Fig. 3), though heterogeneity in reporting prevented definitive statistical analysis. Technical variations including crural closure techniques (simple suture vs. pledgeted vs. mesh reinforced) and fundoplication type (Nissen vs. Toupet vs. Dor) were inadequately standardized across studies (Table 4). Patient factors including BMI (> 35 kg/m2), advanced age (> 70 years), and comorbidities (diabetes, chronic steroid use) showed inconsistent associations with revision risk, with only 6 of 14 cohorts performing multivariate analysis to control for confounding variables. CONCLUSION: Hernia size consistently emerges as the primary determinant of revision following RHHR, with larger hernias demonstrating substantially higher revision rates regardless of surgical approach. Based on available data, the 5-year revision rate for RHHR ranges from 0 to 5.7%, with an estimated weighted average of 3.2%. Technical considerations including mesh reinforcement and reconstruction methods remain incompletely understood due to significant reporting variations across studies. Patient-specific factors require further investigation through adequately powered prospective studies. Future research demands rigorous prospective designs with standardized documentation of surgical techniques, hernia characteristics, and patient profiles to better identify and stratify revision risk factors after RHHR. The development of consensus guidelines for reporting outcomes in hiatal hernia surgery would facilitate meaningful comparison across studies and improve our understanding of optimal surgical approaches.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Asiedu J, Shadaloey S, Marks A, et al. Adults undergoing robotic hiatal hernia repair: do surgical and patient factors predict 5-year revision? A systematic review. Surg Endosc. 2026. PMID: 42463531. doi:10.1007/s00464-026-13127-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。